Both in Pharmaceuticals
Unicycive Therapeutics vs Immunic
Over the past year UNCY returned −19.1% and IMUX returned +1.6%; their daily moves had a correlation of 0.05.
UNCY −19.1% IMUX +1.6%Growth of $1, one year, split-adjusted
| Metric | UNCY | IMUX |
|---|---|---|
| Price | $3.59 | $7.60 |
| Market cap | $100.0M | $103.7M |
| Today | +2.87% | +3.54% |
| 1 month | −14.3% | −5.8% |
| 6 months | −55.6% | −32.6% |
| Year to date | −37.8% | +42.4% |
| 1 year | −24.4% | −2.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $61.4M | $155.1M |
| Dividend yield | — | — |
| Volatility (60d) | 55.8% | 75.7% |
| Short % of float | 17.8% | 17.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).